LOREN GARZA: Open Payments
NPI 1346850294 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 77 payments from 12 companies in 2025. Trend: 2023 $1,036 · 2024 $1,548 · 2025 $1,208
Food & beverage: $1,208
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $367 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $267 |
| Janssen Biotech, Inc. | 9 | $239 |
| Madrigal Pharmaceuticals | 3 | $69 |
| PFIZER INC. | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 6 | $52 |
| GENZYME CORPORATION | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 2 | $32 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $21 |
Products named: XIFAXAN, TREMFYA, RINVOQ, LINZESS, REZDIFFRA, SKYRIZI, VOQUEZNA, XELJANZ.
Industry payments across KY — which companies pay providers there.
